An interventional study of Joint and muscle gel Puressentiel in Pain and Joint Pain, sponsored by Marco Pacchioni. Status unknown at 1 site in France. Open to participants aged 45 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-02-10.
Sponsored by Marco Pacchioni · Not applicable, Interventional, and Treatment
This clinical trial aims to evaluate the antalgic effect of Puressentiel Joints and Muscles - Gel with 14 essential oils for 12 weeks on knee joint pain in 45 patients suffering from chronic pain related to arthritis of the knee. The evaluation of the puressentiel antalgic effect Joints and Muscles - Gel with 14 essential oils will be done by an algo-functional score of WOMAC based on items of pain, joint stiffness and locomotor function (main criterion), a visual analog scale EVA (graduated from 1 to 10) of the pain by self-assessment of the patient during the consultation and the number of daily analgesics and anti-inflammatory drugs (secondary criteria).
This clinical trial aims to evaluate the antalgic effect of Puressentiel Joints and Muscles - Gel with 14 essential oils for 12 weeks on knee joint pain in 45 patients suffering from chronic pain related to arthritis of the knee. The patients included in the study will be consultants from the Department of Physical Medicine, Rehabilitation and Sports Trauma at Foch Hospital in Suresnes and will have to present chronic pain related to arthritis of the knee either with or without antalgic and anti-inflammatory treatment. The evaluation of the puressentiel antalgic effect Joints and Muscles - Gel with 14 essential oils will be evaluated by an algo-functional score of WOMAC based on items of pain, joint stiffness and locomotor function (main criterion), a visual analog scale EVA (graduated from 1 to 10) of the pain by self-assessment of the patient during each visit and the number of daily antalgic and anti-inflammatory drugs (secondary criteria).
273 studies on the registry are indexed under Arthralgia; 41 are open to participants now.
This study's planned enrollment of 40 is below the median of 63 across 219 interventional studies indexed under Arthralgia.
Browse Arthralgia studies →This is the only study on the registry with Marco Pacchioni as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Administration of joints and muscle gel Puressentiel containing of 14 essential oils
Device: Joint and muscle gel Puressentiel
To evaluate the antalgic effect in patients with chronic pain related to osteoarthritis of the knee when applied to the skin of Puressentiel Joints and Muscles - Gel with 14 essential oils.
Womac score is the primary outcome
Scoring pain and locomotion with a maximum score (worse of 96). A change of 16 points is considered as a significant clinical improvement
Time frame: 30 days
Pain visual analog analog scale is the secondary outcome
Scoring pain from 1 to 100 (worse)
Time frame: 30 days
Pain visual analog scale
Pain visual analog scale scored from 0 to 100(worse). A change of 10 points is considered as clinically significant
Time frame: Evaluation at inclusion and after 30 days
This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.